현상

이상약물반응

1편 · 2026 1편

Enhancing Safety Signaling: Integrating Clinical Trials and Post-Marketing Adverse Event Reports
MSOM · 2026 · 인용 0 · Fernanda Bravo, Lawrence Yunliang Chen, John Silberholz